Cyclophosphamide

Overview

Cyclophosphamide is an alkylating agent used in the treatment of various types of cancer and certain autoimmune diseases. It works by interfering with the growth and replication of cancer cells.

API suppliers (11)

Suppliers of Cyclophosphamide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• NAVINTA LLCUnited States2 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF
• PHARM ECO LABORATORIES INC
• DEGUSSA HULS AG
• OLAINFARM JOINT STOCK CO
• LIANYUNGANG PHARMACEUTICAL FACTORY

Patent & exclusivity (US)

Per the FDA Orange Book (54 approved US products), the latest listed US patent on Cyclophosphamide expires 15 Feb 2036. Generic API sourcing typically opens up once these lapse.

Therapeutic areas